Enhancement of methoxamine-induced contractile responses of rat ventricular muscle in streptozotocin-induced diabetes is associated with α1A adrenoceptor upregulation

Acta Physiologica

Volumn 188, Issue 3-4, 2006, Pages 173-183

  Kamata, K ^a   Satoh, T ^a   Matsumoto, T ^a   Noguchi, E ^a   Taguchi, K ^a   Kobayashi, T ^a   Tanaka, H ^b   Shigenobu, K ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Contraction; Diabetes; Heart; Isoproterenol; Methoxamine; Papillary muscle; Streptozotocin; Time course

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; CALCIUM ION; ISOPRENALINE; MESSENGER RNA; METHOXAMINE; RYANODINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART CONTRACTION; HEART FUNCTION; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; INOTROPISM; MALE; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SARCOPLASMIC RETICULUM; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM CHANNEL AGONISTS; DIABETES MELLITUS, EXPERIMENTAL; HEART VENTRICLES; ISOPROTERENOL; MALE; METHOXAMINE; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; RYANODINE; UP-REGULATION; VASOCONSTRICTOR AGENTS;

EID: 33750292527     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2006.01616.x     Document Type: Article

References (51)

1. Bruckner, R., Meyer, W., Mugge, A., Schmitz, W. & Scholz, H. 1984. Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur J Pharmacol 99, 345-347.
2. Chomczynski, P. & Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 162, 156-159.
3. Deng, X.F., Chemtob, S. & Verma, D.R. 1996. Characterization of alpha 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol 119, 269-276.
4. Dillmann, W.H. 1989. Diabetes and thyroid-hormone-induced changes in cardiac function and their molecular basis. Annu Rev Med 40, 373-394.
5. Dincer, U.D., Bidasee, K.R., Guner, S., Tay, A., Ozcelikay, A.T. & Altan, V.M. 2001. The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoceptors in rat hearts. Diabetes 50, 455-461.
6. Dincer, U.D., Guner, S., Tay, A., Arioglu, E., Tasdelen, A., Aslamaci, S. & Bidasee, K.R. 2003. Decreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendage. Cardiovasc Diabetol 20, 2-6.
7. Endoh, M., Hiramoto, T., Ishihara, A., Takahashi, M. & Inui, J. 1991. Myocardial alpha 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ Res 68, 1179-1180.
8. Endoh, M., Takanashi, M. & Norota, I. 1992. Role of alpha 1A adrenoceptor subtype in production of the positive inotropic effect mediated via myocardial alpha 1 adrenoceptors in the rabbit papillary muscle: influence of selective alpha 1A subtype antagonists WB4101 and 5-methylurapildil. Naunyn Schmiedebergs Arch Pharmacol 345, 578-585.
9. Ertl, R., Jahnel, U., Nawrath, H., Carmeliet, E. & Vereecke, J. 1991. Differential electrophysiologic and inotropic effects of phenylephrine in atrial and ventricular heart muscle preparations from rats. Naunyn Schmiedebergs Arch Pharmacol 344, 574-581.
10. Gando, S., Hattori, Y., Akaishi, Y., Nishihira, J. & Kanno, M. 1997. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 282, 475-484.
11. Gotzsche, O. 1983. The adrenergic beta-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin-diabetic rats. In vivo and in vitro evidence for a desensitized myocardial beta-receptor. Diabetes 32, 1110-1116.
12. Graham, R.M., Perez, D.M., Hwa, J. & Piascik, M.T. 1996. Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 78, 737-749.
13. Gunasekaran, S., Young, J.A. & Tenner, T.E., Jr. 1993. Pharmacological study of isoproterenol and diabetic cardiomyopathies in rat right ventricular strips. Pharmacology 46, 101-108.
14. Hamby, R.I., Zoneraich, S. & Sherman, L. 1974. Diabetic cardiomyopathy. J Am Med Assoc 229, 1749-1754.
15. Hammond, H.K., Roth, D.A., Insel, P.A. et al. 1992. Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion. Circulation 85, 269-280.
16. Hattori, Y. & Kanno, M. 1998. Role of alpha1-adrenoceptor subtypes in production of the positive inotropic effects in mammalian myocardium: implications for the alpha1-adrenoceptor subtype distribution. Life Sci 62, 1449-1453.
17. Heijnis, J.B. & van Zwieten, P.A. 1992. Enhanced inotropic responsiveness to alpha 1-adrenoceptor stimulation in isolated working hearts from diabetic rats. J Cardiovasc Pharmacol 20, 559-562.
18. Heyliger, C.E., Pierce, G.N., Singal, P.K., Beamish, R.E. & Dhalla, N.S. 1982. Cardiac alpha- and beta-adrenoceptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 77, 610-618.
19. Hieble, J.P., Bylund, D.B., Clarke, D.E., Eikenburg, D.C., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P. & Ruffolo, R.R. Jr. 1995. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47, 267-270.
20. Homma, N., Hirasawa, A., Shibata, K., Hashimoto, K. & Tsujimoto, G. 2000. Both alpha(1A)-and alpha(1B)-adrenergic receptor subtypes couple to the transient outward current (I(To)) in rat ventricular myocytes. Br J Pharmacol 129, 1113-1120.
21. IUPHAR Committee of Receptor Nomenclature and Drug Classification. 1995. Receptor & ion channel nomenclature supplement. Trends Pharmacol Sci Nomenclature Suppl 16, 9-12.
22. Jahnel, U., Duwe, E., Pfennigsdorf, S. & Nawrath, H. 1994. On the mechanism of action of phenylephrine in rat atrial heart muscle. Naunyn Schmiedebergs Arch Pharmacol 349, 408-415.
23. Kamata, K., Satoh, T., Tanaka, H. & Shigenobu, K. 1997. Changes in electrophysiological and mechanical responses of the rat papillary muscle to alpha- and beta-agonist in streptozotocin-induced diabetes. Can J Physiol Pharmacol 75, 781-788.
24. Kobayashi, T. & Kamata, K. 1999. Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats. Eur J Pharmacol 367, 213-222.
25. Kobayashi, T., Matsumoto, T. & Kamata, K. 2005. IGF-I-induced enhancement of contractile response in organ-cultured aortae from diabetic rats is mediated by sustained thromboxane A2 release from endothelial cells. J Endocrinol 186, 367-376.
26. Lafci-Erol, D., Altan, V.M. & Ozturk, Y. 1994. Increased alpha 1-adrenergic responsiveness of alloxan diabetic rat atria: effects of insulin therapy and thyroidectomy. Gen Pharmacol 25, 559-564.
27. Lee, J.R., Zhang, X.J., Lin, B.K., Reigel, C.E. & Tenner, T.E. Jr. 2004. Altered inotropic reactivity in diabetic rabbit right ventricular myocardium. Can J Physiol Pharmacol 82, 903-910.
28. Makino, A. & Kamata, K. 2000. Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats. Diabetes Obes Metab 2, 47-55.
29. Matsumoto, T., Kobayashi, T. & Kamata, K. 2003. Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 285, H283-H291.
30. Matsumoto, T., Wakabayashi, K., Kobayashi, T. & Kamata, K. 2004. Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery. Am J Physiol Heart Circ Physiol 287, H1064-H1071.
31. Matsumoto, T., Wakabayashi, K., Kobayashi, T. & Kamata, K. 2005. Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 289, H2234-H2243.
32. Molenaar, P., Smolich, J.J., Russell, F.D., McMartin, L.R. & Summers, R.J. 1990. Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J Pharmacol Exp Ther 255, 393-400.
33. Montanari, D., Yin, H., Dobrzynski, E., Agata, J., Yoshida, H., Chao, J. & Chao, L. 2005. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes 54, 1573-1580.
34. Nagashima, M., Hattori, Y., Akaishi, Y., Tohse, N., Sakuma, I., Kitabatake, A. & Kanno, M. 1996. Alpha 1-adrenoceptor subtypes mediating inotropic and electrophysiological effects in mammalian myocardium. Am J Physiol 271, H1423-H1432.
35. Nagashima, M., Hattori, Y., Tohse, N. & Kanno, M. 1997. Alpha 1-adrenoceptor subtype involved in the positive and negative inotropic responses to phenylephrine in rat papillary muscle. Gen Pharmacol 28, 721-725.
36. Ouwens, D.M., Boer, C., Fodor, M., de Galan, P., Heine, R.J., Maassen, J.A. & Diamant, M. 2005. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signaling in rats. Diabetologia 48, 1229-1237.
37. Pacher, P., Ungvari, Z., Nanasi, P.P. & Kecskemeti, V. 1999. Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand 166, 7-13.
38. Pierce, G.N. & Russell, J.C. 1997. Regulation of intracellular Ca2+ in the heart during diabetes. Cardiovasc Res 34, 41-47.
39. Price, D.T., Lefkowitz, R.J., Caron, M.G., Berkowitz, D. & Schwinn, D.A. 1994. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol Pharmacol 45, 171-175.
40. Sutko, J.L. & Willerson, J.T. 1980. Ryanodine alteration of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues. Circ Res 46, 332-343.
41. Sutko, J.L., Willerson, J.T., Templeton, G.H., Jones, L.R. & Besch, H.R. Jr. 1979. Ryanodine: its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharmacol Exp Ther 209, 37-47.
42. Tamada, A., Hattori, Y., Houzen, H. et al. 1998. Effects of beta-adrenoceptor stimulation on contractility, [Ca2+]i, and Ca2+ current in diabetic rat cardiomyocytes. Am J Physiol 274, H1849-1857.
43. Tanaka, H. & Shigenobu, K. 1989. Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J Mol Cell Cardiol 21, 1305-1313.
44. Tanaka, H., Manita, S. & Shigenobu, K. 1994. Increased sensitivity of neonatal mouse myocardia to autonomic transmitters. J Auton Pharmacol 14, 123-128.
45. Tanaka, H., Manita, S., Matsuda, T., Adachi, M. & Shigenobu, K. 1995. Sustained negative inotropism mediated by alpha-adrenoceptors in adult mouse myocardia: developmental conversion from positive response in the neonate. Br J Pharmacol 114, 673-677.
46. Tohse, N., Hattori, Y., Nakaya, H. & Kanno, M. 1987. Effects of alpha-adrenoceptor stimulation on electrophysiological properties and mechanics in rat papillary muscle. Gen Pharmacol 18, 539-546.
47. Wald, M., Borda, E.S. & Sterin-Borda, L. 1988. Alpha-adrenergic supersensitivity and decreased number of alpha-adrenoceptors in heart from acute diabetic rats. Can J Physiol Pharmacol 66, 1154-1160.
48. Williams, R.S., Schaible, T.F., Scheuer, J. & Kennedy, R. 1983. Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium. Diabetes 32, 881-886.
49. Yu, Z. & McNeill, J.H. 1991. Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy. J Pharmacol Exp Ther 257, 64-71.
50. Zhang, Y., Xu, K. & Han, C. 1997. Alterations of cardiac alpha 1-adrenoceptor subtypes in hypothyroid rats. Clin Exp Pharmacol Physiol 24, 481-486.
51. Zhang, Y.Y., Xu, K.M. & Han, C. 1999. Alpha(1)-adrenoceptor subtypes mediating inotropic responses in rat heart. J Pharmacol Exp Ther 291, 829-836.